Advantages of the Papillon protocol in the preoperative treatment of rectal carcinoma

Vicki Klimberg, James D. Langston, Ann Maners, John C. Gocio, Laura F. Hutchins, Nicholas P. Lang, Kent C. Westbrook, John R. Broadwater

Research output: Contribution to journalArticle

Abstract

Standard treatment for advanced rectal carcinoma currently includes surgery, radiotherapy, and chemotherapy. Although there are theoretic advantages to preoperative irradiation, it is often not performed because of the prolonged delay of surgery and the purported increase in perioperative complications. A pilot study was undertaken at our institution to evaluate a treatment protocol advocated by Dr. Papillon that offers a shorter treatment time and less patient morbidity than conventional preoperative therapy for rectal carcinoma. Twenty patients with rectal cancer underwent the preoperative regimen that consisted of 3,000 cGy delivered in 10 fractions over 12 days with concomitant 5-fluorouracil and mitomycin-C. Complications were acceptable. Local recurrence was lower than in most reported trials, and survival rates were comparable. Additional benefits of the protocol include lower radiation morbidity to the patient and a decreased delay between diagnosis and surgery.

Original languageEnglish (US)
Pages (from-to)433-436
Number of pages4
JournalThe American Journal of Surgery
Volume164
Issue number5
DOIs
StatePublished - 1992
Externally publishedYes

Fingerprint

Carcinoma
Morbidity
Mitomycin
Rectal Neoplasms
Clinical Protocols
Fluorouracil
Radiotherapy
Therapeutics
Survival Rate
Radiation
Recurrence
Drug Therapy

ASJC Scopus subject areas

  • Surgery

Cite this

Klimberg, V., Langston, J. D., Maners, A., Gocio, J. C., Hutchins, L. F., Lang, N. P., ... Broadwater, J. R. (1992). Advantages of the Papillon protocol in the preoperative treatment of rectal carcinoma. The American Journal of Surgery, 164(5), 433-436. https://doi.org/10.1016/S0002-9610(05)81175-4

Advantages of the Papillon protocol in the preoperative treatment of rectal carcinoma. / Klimberg, Vicki; Langston, James D.; Maners, Ann; Gocio, John C.; Hutchins, Laura F.; Lang, Nicholas P.; Westbrook, Kent C.; Broadwater, John R.

In: The American Journal of Surgery, Vol. 164, No. 5, 1992, p. 433-436.

Research output: Contribution to journalArticle

Klimberg, V, Langston, JD, Maners, A, Gocio, JC, Hutchins, LF, Lang, NP, Westbrook, KC & Broadwater, JR 1992, 'Advantages of the Papillon protocol in the preoperative treatment of rectal carcinoma', The American Journal of Surgery, vol. 164, no. 5, pp. 433-436. https://doi.org/10.1016/S0002-9610(05)81175-4
Klimberg, Vicki ; Langston, James D. ; Maners, Ann ; Gocio, John C. ; Hutchins, Laura F. ; Lang, Nicholas P. ; Westbrook, Kent C. ; Broadwater, John R. / Advantages of the Papillon protocol in the preoperative treatment of rectal carcinoma. In: The American Journal of Surgery. 1992 ; Vol. 164, No. 5. pp. 433-436.
@article{d24b2b6ab72345099df0d958ff048c21,
title = "Advantages of the Papillon protocol in the preoperative treatment of rectal carcinoma",
abstract = "Standard treatment for advanced rectal carcinoma currently includes surgery, radiotherapy, and chemotherapy. Although there are theoretic advantages to preoperative irradiation, it is often not performed because of the prolonged delay of surgery and the purported increase in perioperative complications. A pilot study was undertaken at our institution to evaluate a treatment protocol advocated by Dr. Papillon that offers a shorter treatment time and less patient morbidity than conventional preoperative therapy for rectal carcinoma. Twenty patients with rectal cancer underwent the preoperative regimen that consisted of 3,000 cGy delivered in 10 fractions over 12 days with concomitant 5-fluorouracil and mitomycin-C. Complications were acceptable. Local recurrence was lower than in most reported trials, and survival rates were comparable. Additional benefits of the protocol include lower radiation morbidity to the patient and a decreased delay between diagnosis and surgery.",
author = "Vicki Klimberg and Langston, {James D.} and Ann Maners and Gocio, {John C.} and Hutchins, {Laura F.} and Lang, {Nicholas P.} and Westbrook, {Kent C.} and Broadwater, {John R.}",
year = "1992",
doi = "10.1016/S0002-9610(05)81175-4",
language = "English (US)",
volume = "164",
pages = "433--436",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Advantages of the Papillon protocol in the preoperative treatment of rectal carcinoma

AU - Klimberg, Vicki

AU - Langston, James D.

AU - Maners, Ann

AU - Gocio, John C.

AU - Hutchins, Laura F.

AU - Lang, Nicholas P.

AU - Westbrook, Kent C.

AU - Broadwater, John R.

PY - 1992

Y1 - 1992

N2 - Standard treatment for advanced rectal carcinoma currently includes surgery, radiotherapy, and chemotherapy. Although there are theoretic advantages to preoperative irradiation, it is often not performed because of the prolonged delay of surgery and the purported increase in perioperative complications. A pilot study was undertaken at our institution to evaluate a treatment protocol advocated by Dr. Papillon that offers a shorter treatment time and less patient morbidity than conventional preoperative therapy for rectal carcinoma. Twenty patients with rectal cancer underwent the preoperative regimen that consisted of 3,000 cGy delivered in 10 fractions over 12 days with concomitant 5-fluorouracil and mitomycin-C. Complications were acceptable. Local recurrence was lower than in most reported trials, and survival rates were comparable. Additional benefits of the protocol include lower radiation morbidity to the patient and a decreased delay between diagnosis and surgery.

AB - Standard treatment for advanced rectal carcinoma currently includes surgery, radiotherapy, and chemotherapy. Although there are theoretic advantages to preoperative irradiation, it is often not performed because of the prolonged delay of surgery and the purported increase in perioperative complications. A pilot study was undertaken at our institution to evaluate a treatment protocol advocated by Dr. Papillon that offers a shorter treatment time and less patient morbidity than conventional preoperative therapy for rectal carcinoma. Twenty patients with rectal cancer underwent the preoperative regimen that consisted of 3,000 cGy delivered in 10 fractions over 12 days with concomitant 5-fluorouracil and mitomycin-C. Complications were acceptable. Local recurrence was lower than in most reported trials, and survival rates were comparable. Additional benefits of the protocol include lower radiation morbidity to the patient and a decreased delay between diagnosis and surgery.

UR - http://www.scopus.com/inward/record.url?scp=0027105191&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027105191&partnerID=8YFLogxK

U2 - 10.1016/S0002-9610(05)81175-4

DO - 10.1016/S0002-9610(05)81175-4

M3 - Article

VL - 164

SP - 433

EP - 436

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

IS - 5

ER -